Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant
Clinical and Radiographic Evaluation of Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant: A Randomized Clinical Study
Suez Canal University
16 participants
Aug 13, 2025
INTERVENTIONAL
Conditions
Summary
The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant
Eligibility
Inclusion Criteria4
- Adult(male or female) patients between the ages of 21 -50 years who requiring the replacement of one or more non-restorable teeth in the mandible which will be indicated for extraction.
- Adequate bone dimensions at the implant site with ridge width of at least 6 mm, the availability of at least 3mm of sound subapical bone, the presence of an intact labial bone plate, and no evidance of periapical infection on cone beam computed tomography or clinically
- The peri-implant gaps larger than 1.5 mm will be included.
- All patients will be physically healthy with no medical history of any systemic disease.
Exclusion Criteria7
- Smokers.
- Patients with para functional habits such as bruxism and clenching
- Poorly controlled systemic diseases which preclude local anesthesia or surgical procedures
- Patients undergoing chemotherapy or radiotherapy and immuno-compromised patients.
- Pregnant /lactating women.
- Patients that are allergic to zinc
- Patients on antibiotic therapy in the pervious 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
patients will undergo immediate implant with bovine drived hydroxyapatite xenograft.
patients will undergo immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07187609